KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas

Cancer Research

Volumn 70, Issue 16, 2010, Pages 6516-6526

  Cheng, Yingduan ^a   Geng, Hua ^a   Cheng, Suk Hang ^b   Liang, Pei ^b   Bai, Yan ^c   Li, Jisheng ^a   Srivastava, Gopesh ^d   Ng, Margaret H L ^b   Fukagawa, Tatsuo ^e   Wu, Xiushan ^c   Chan, Anthony T C ^a   Tao, Qian ^a  

^a Li Ka Shing Institute of Health Sciences   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HUNAN NORMAL UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 6; HELIX LOOP HELIX PROTEIN; HETEROCHROMATIN PROTEIN 1; HIGH MOBILITY GROUP A2 PROTEIN; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MYC PROTEIN; STAT3 PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ZNF382; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; DNA BINDING PROTEIN; I KAPPA B KINASE; ID1 PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 1; STAT3 PROTEIN, HUMAN; STAT5 PROTEIN; STAT5B PROTEIN, HUMAN; TRANSCRIPTION FACTOR; ZNF382 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOMA; CARCINOMA CELL; CELL PROLIFERATION; CLONOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; ESOPHAGUS CARCINOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE SILENCING; HETEROCHROMATIN; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CARCINOMA; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; TRANSCRIPTION INITIATION SITE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL GROWTH; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; GENETICS; HCT116 CELL LINE; METABOLISM; MULTIPLE CANCER; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL GROWTH PROCESSES; CERCOPITHECUS AETHIOPS; COS CELLS; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HCT116 CELLS; HUMANS; I-KAPPA B KINASE; INHIBITOR OF DIFFERENTIATION PROTEIN 1; NEOPLASMS, MULTIPLE PRIMARY; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 77955728660     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-4566     Document Type: Article

References (50)

1. Coleman WB, Tsongalis GJ. Molecular mechanisms of human carcinogenesis. EXS 2006;96:321-49.
2. Hayslip J, Montero A. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review. Mol Cancer 2006;5:44. (Pubitemid 44712390)
3. Herman JG. Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol 1999;9:359-67.
4. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
5. Cowger JJ, Zhao Q, Isovic M, Torchia J. Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence. Oncogene 2007;26:3378-86. (Pubitemid 46788885)
6. Yang M, Wu S, Su X, May WS. JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity. Blood 2006;108:4136-45. (Pubitemid 44913285)
7. Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol 2003;4:231.
8. Tian C, Xing G, Xie P, et al. KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol 2009;11:580-91.
9. Huang C, Jia Y, Yang S, et al. Characterization of ZNF23, a KRAB-containing protein that is downregulated in human cancers and inhibits cell cycle progression. Exp Cell Res 2007;313:254-63. (Pubitemid 46048814)
10. Tan W, Zheng L, Lee WH, Boyer TG. Functional dissection of transcription factor ZBRK1 reveals zinc fingers with dual roles in DNA-binding and BRCA1-dependent transcriptional repression. J Biol Chem 2004;279:6576-87. (Pubitemid 38248794)
11. Tsuda H, Takarabe T, Okada S, et al. Different pattern of loss of heterozygosity among endocervical-type adenocarcinoma, endometrioid-type adenocarcinoma and adenoma malignum of the uterine cervix. Int J Cancer 2002;98:713-7. (Pubitemid 34225621)
12. Du PL, Dietzsch E, Van GM, et al. Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the Black and Colored populations of South Africa. Cancer Res 1999;59:1877-83.
13. Shao JY, Huang XM, Yu XJ, et al. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res 2001;21:3021-9.
14. Luo K, Yuan W, Zhu C, et al. Expression of a novel Krupple-like zinc-finger gene, ZNF382, in human heart. Biochem Biophys Res Commun 2002;299:606-12.
15. Cui Y, Ying Y, van HA, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS ONE 2008;3:e2990.
16. Ying J, Li H, Seng TJ, et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006;25:1070-80. (Pubitemid 43277014)
17. Liu XQ, Chen HK, Zhang XS, et al. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 2003;106:60-5.
18. Wang Y, Li J, Cui Y, et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res 2009;69:5194-201.
19. Tao Q, Huang H, Geiman TM, et al. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 2002;11:2091-102. (Pubitemid 34993997)
20. Qiu GH, Tan LK, Loh KS, et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 2004;23:4793-806.
21. Fukagawa T, Nogami M, Yoshikawa M, et al. Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat Cell Biol 2004;6:784-91. (Pubitemid 39144485)
22. Ying J, Li H, Yu J, et al. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/β-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 2008;14:55-61. (Pubitemid 351377978)
23. Gebelein B, Fernandez-Zapico M, Imoto M, Urrutia R. KRAB-independent suppression of neoplastic cell growth by the novel zinc finger transcription factor KS1. J Clin Invest 1998;102:1911-9.
24. Gebelein B, Urrutia R. Sequence-specific transcriptional repression by KS1, a multiple-zinc-finger-Kruppel-associated box protein. Mol Cell Biol 2001;21:928-39. (Pubitemid 32104740)
25. Basseres DS, Baldwin AS. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 2006;25:6817-30.
26. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-68.
27. Lee H, Herrmann A, Deng JH, et al. Persistently activated Stat3 maintains constitutive NF-κB activity in tumors. Cancer Cell 2009;15:283-93.
28. Han X, Ren X, Jurickova I, et al. Regulation of intestinal barrier function by signal transducer and activator of transcription 5b. Gut 2009;58:49-58.
29. Boehm JS, Zhao JJ, Yao J, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007;129:1065-79. (Pubitemid 46891036)
30. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC. Id-1 expression promotes cell survival through activation of NF-κB signalling pathway in prostate cancer cells. Oncogene 2003;22:4498-508. (Pubitemid 36920693)
31. Ryan RF, Schultz DC, Ayyanathan K, et al. KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. Mol Cell Biol 1999;19:4366-78. (Pubitemid 29242011)
32. Best JD, Carey N. Epigenetic opportunities and challenges in cancer. Drug Discov Today 2010;15:65-70.
33. Wiznerowicz M, Jakobsson J, Szulc J, et al. The Kruppel-associated box repressor domain can trigger de novo promoter methylation during mouse early embryogenesis. J Biol Chem 2007;282:34535-41. (Pubitemid 350159433)
34. Li X, Ito M, Zhou F, et al. A maternal-zygotic effect gene, Zfp57, maintains both maternal and paternal imprints. Dev Cell 2008;15:547-57.
35. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ III. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 2002;16:919-32. (Pubitemid 34408542)
36. Wynter Coral, Alfonzo Marcelo, Lippo de Becemberg Itala. Tumorigenesis is a disease of heterochromatin assembly and disruption of the epigenetic mark. In: Wong David K., editor. Tumorigenesis Research Advances. Nova Science publishers; 2007, p. 201-226.
37. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008;8:976-90.
38. Dynek JN, Chan SM, Liu J, Zha J, Fairbrother WJ, Vucic D. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res 2008;68:3124-32.
39. Steinman RA. Cell cycle regulators and hematopoiesis. Oncogene 2002;21:3403-13.
40. Joo A, Aburatani H, Morii E, Iba H, Yoshimura A. STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression. Oncogene 2004;23:726-34. (Pubitemid 38241273)
41. Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A. Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 2002;21:2971-80. (Pubitemid 34522896)
42. Di CF, Hillion J, Hristov A, et al. HMGA2 participates in transformation in human lung cancer. Mol Cancer Res 2008;6:743-50.
43. Kim H, Chung H, Kim HJ, et al. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-κB in MCF-7 breast cancer cells. Breast Cancer Res Treat 2008;112:287-96.
44. Hellerbrand C, Bumes E, Bataille F, Dietmaier W, Massoumi R, Bosserhoff AK. Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 2007;28:21-7. (Pubitemid 44942623)
45. Kashima L, Toyota M, Mita H, et al. CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-κB. Oncogene 2009;28:2643-53.
46. Fujioka S, Niu J, Schmidt C, et al. NF-κB and AP-1 connection: mechanism of NF-κB-dependent regulation of AP-1 activity. Mol Cell Biol 2004;24:7806-19. (Pubitemid 39121503)
47. Wang Q, Sun Z, Yang HS. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both κ-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 2008;27:1527-35. (Pubitemid 351347877)
48. Wang L, Zhang Y, Li H, Xu Z, Santella RM, Weinstein IB. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. Cancer Res 2007;67:4700-8. (Pubitemid 46910176)
49. Ki SH, Choi MJ, Lee CH, Kim SG. Gα12 specifically regulates COX-2 induction by sphingosine 1-phosphate. Role for JNK-dependent ubiquitination and degradation of IκBα. J Biol Chem 2007;282:1938-47.
50. Parnell SC, Magenheimer BS, Maser RL, Zien CA, Frischauf AM, Calvet JP. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J Biol Chem 2002;277:19566-72.